Hypothermia prolongs the time-course of action of non-depolarizing neuromuscular blocking agents. The mechanism, however, is unknown. We studied the influence of hypothermia (by surface cooling, nasopharyngeal temperature less than or equal to 31 degrees C) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Nineteen neurosurgical patients were divided into hypothermic and normothermic groups. Hypothermia (30.4 +/- 0.8 degrees C (mean +/- SD)) increased the duration of action, temperature dependently, and delayed the recovery. Hypothermia reduced the plasma clearance significantly (2.17 +/- 0.62 vs. 4.26 +/- 0.50 mL kg(-1) min(-1), P = 0.004), did not change the volume of distribution (224 +/- 64 vs. 232 +/- 60...
The approach to sedation, analgesia, and neuromuscular blockade during targeted temperature manageme...
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs stud...
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing ...
Hypothermia prolongs the time-course of action of non-depolarizing neuromuscular blocking agents. Th...
In 10 patients scheduled for elective coronary artery bypass grafting under midazolam-sufentanil ana...
Objective: To study the influence of hypothermic cardiopulmonary bypass (CPB) on the pharmacodynamic...
The influence of hypothermia (27℃) on the action of nondepolarizing neuromuscular blocking drugs was...
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs stud...
Therapeutic hypothermia is increas-ingly common in the intensive care unit (ICU), especially for pro...
[[abstract]]INTRODUCTION: Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting...
Rocuronium is a new non-depolarising agent with an intermediate time-course of neuromuscular blockin...
has been used for medicinal purposes since ancient times. This paper re-views the current potential ...
It has been shown that changes in body core temperature several hours after a transient ischemic ins...
[[abstract]]Chemotherapy-induced peripheral neuropathy (CIPN) is a severe adverse effect that occurs...
The approach to sedation, analgesia, and neuromuscular blockade during targeted temperature manageme...
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs stud...
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing ...
Hypothermia prolongs the time-course of action of non-depolarizing neuromuscular blocking agents. Th...
In 10 patients scheduled for elective coronary artery bypass grafting under midazolam-sufentanil ana...
Objective: To study the influence of hypothermic cardiopulmonary bypass (CPB) on the pharmacodynamic...
The influence of hypothermia (27℃) on the action of nondepolarizing neuromuscular blocking drugs was...
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs stud...
Therapeutic hypothermia is increas-ingly common in the intensive care unit (ICU), especially for pro...
[[abstract]]INTRODUCTION: Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting...
Rocuronium is a new non-depolarising agent with an intermediate time-course of neuromuscular blockin...
has been used for medicinal purposes since ancient times. This paper re-views the current potential ...
It has been shown that changes in body core temperature several hours after a transient ischemic ins...
[[abstract]]Chemotherapy-induced peripheral neuropathy (CIPN) is a severe adverse effect that occurs...
The approach to sedation, analgesia, and neuromuscular blockade during targeted temperature manageme...
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs stud...
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing ...